Pierre Geborek

affiliated with the university
More filtering options
  1. 2020
  2. 2019
  3. 2018
  4. 2017
  5. Treatment with belimumab in SLE does not alter antobody response to 13-valent pneumococcal vaccine

    Johanna Nagel, Tore Saxne, Pierre Geborek, Anders Bengtsson, S Jacobsen, Svaerke Joergensen C, Jan-Åke Nilsson, Lillemor Skattum, Andreas Jönsen & Meliha C Kapetanovic, 2017, In : Lupus. 26, 10, p. 1072-1081

    Research output: Contribution to journalArticle

  6. 2016
  7. Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis: Observational Data from Southern Sweden

    JOHAN KARLSSON WALLMAN, Jonas K. Eriksson, Jan Åke Nilsson, Tor Olofsson, Lars Erik Kristensen, Martin Neovius & Pierre Geborek, 2016 Jul 1, In : Journal of Rheumatology. 43, 7, p. 1292-1299 8 p.

    Research output: Contribution to journalArticle

  8. Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.

    Alf Kastbom, Kristina Forslind, Sofia Ernestam, Pierre Geborek, Johan Karlsson, Ingemar Petersson, Saedis Saevarsdottir, Lars Klareskog, Ronald F van Vollenhoven & Karin Lundberg, 2016, In : Annals of the Rheumatic Diseases. 75, 2, p. 356-361

    Research output: Contribution to journalArticle

  9. Effectiveness and Feasibility Associated with Switching to a Second or Third TNF Inhibitor in Patients with Psoriatic Arthritis: A Cohort Study from Southern Sweden.

    Lars Erik Kristensen, Elisabeth Lie, Lennart Jacobsson, Robin Christensen, Philip J Mease, Henning Bliddal & Pierre Geborek, 2016, In : Journal of Rheumatology. 43, 1, p. 81-87

    Research output: Contribution to journalArticle

  10. 2015
  11. Brief report: enhancement of patient recruitment in rheumatoid arthritis clinical trials using a multi-biomarker disease activity score as an inclusion criterion.

    Ronald F van Vollenhoven, Rebecca Bolce, Karen Hambardzumyan, Saedis Saevarsdottir, Kristina Forslind, Ingemar Petersson, Eric H Sasso, C C Hwang, Oscar G Segurado & Pierre Geborek, 2015, In : Arthritis & Rheumatology. 67, 11, p. 2855-2860

    Research output: Contribution to journalArticle

  12. Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial

    Saedis Saevarsdottir, Hamed Rezaei, Pierre Geborek, Ingemar Petersson, Sofia Ernestam, Kristina Albertsson, Kristina Forslind & Ronald F. van Vollenhoven, 2015, In : Annals of the Rheumatic Diseases. 74, 8, p. 1509-1514

    Research output: Contribution to journalArticle

  13. Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.

    Karen Hambardzumyan, Rebecca Bolce, Saedis Saevarsdottir, Scott E Cruickshank, Eric H Sasso, David Chernoff, Kristina Forslind, Ingemar Petersson, Pierre Geborek & Ronald F van Vollenhoven, 2015, In : Annals of the Rheumatic Diseases. 74, 6, p. 1102-1109

    Research output: Contribution to journalArticle

  14. 2014
  15. Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival

    Irini Flouri, Theodora E. Markatseli, Paraskevi V. Voulgari, Kyriaki A. Boki, Ioannis Papadopoulos, Loukas Settas, Dimitrios Zisopoulos, Fotini N. Skopouli, Alexios Iliopoulos, George K. Bertsias, Pierre Geborek, Alexandros A. Drosos, Dimitrios T. Boumpas & Prodromos Sidiropoulos, 2014, In : Seminars in Arthritis and Rheumatism. 43, 4, p. 447-457

    Research output: Contribution to journalReview article

  16. Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.

    Meliha C Kapetanovic, Lars Erik Kristensen, Tore Saxne, Teodora Aktas, Andreas Mörner & Pierre Geborek, 2014, In : Arthritis Research and Therapy. 16, 1, R2.

    Research output: Contribution to journalArticle

  17. Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort.

    Tor O Olofsson, Ingemar Petersson, Jonas Eriksson, Martin Englund, Julia F Simard, Jan-Åke Nilsson, Pierre Geborek, Lennart Jacobsson, Johan Askling & Martin Neovius, 2014, In : Annals of the Rheumatic Diseases. 73, 5, p. 845-853

    Research output: Contribution to journalArticle

  18. 2013
  19. Biological vs Conventional Combination Treatment and Work Loss in Early Rheumatoid Arthritis A Randomized Trial

    Jonas K. Eriksson, Martin Neovius, Johan Bratt, Ingemar Petersson, Ronald F. van Vollenhoven, Pierre Geborek & Sofia Ernestam, 2013, In : JAMA Internal Medicine. 173, 15, p. 1407-1414

    Research output: Contribution to journalArticle

  20. The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice

    Ingrid Lekander, Fredrik Borgstrom, Jorgen Lysholm, Ronald F. van Vollenhoven, Staffan Lindblad, Pierre Geborek & Gisela Kobelt, 2013, In : European Journal of Health Economics. 14, 6, p. 863-873

    Research output: Contribution to journalArticle

  21. 2012
  22. A survey of spinal collateral actions of feline ventral spinocerebellar tract neurons.

    Pierre Geborek, Elisabeth Nilsson, F Bolzoni & E Jankowska, 2012, In : European Journal of Neuroscience.

    Research output: Contribution to journalArticle

  23. Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial

    Ronald F. van Vollenhoven, Pierre Geborek, Kristina Forslind, Kristina Albertsson, Sofia Ernestam, Ingemar Petersson, Katerina Chatzidionysiou & Johan Bratt, 2012, In : The Lancet. 379, 9827, p. 1712-1720

    Research output: Contribution to journalArticle

  24. Decreased Neutrophil Apoptosis in Quiescent ANCA-Associated Systemic Vasculitis.

    Mohamed AbdGawad, Åsa Pettersson, Lena Gunnarsson, Anders Bengtsson, Pierre Geborek, Lars Nilsson, Mårten Segelmark & Thomas Hellmark, 2012, In : PLoS ONE. 7, 3, e32439.

    Research output: Contribution to journalArticle

  25. In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial

    Hamed Rezaei, Saedis Saevarsdottir, Kristina Forslind, Kristina Albertsson, Helena Wallin, Johan Bratt, Sofi Ernestam, Pierre Geborek, Ingemar Petersson & Ronald F. van Vollenhoven, 2012, In : Annals of the Rheumatic Diseases. 71, 2, p. 186-191

    Research output: Contribution to journalArticle

  26. Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-alpha treatment

    Kaisa Happonen, Tore Saxne, Pierre Geborek, Maria Andersson, Anders Bengtsson, Roger Hesselstrand, Dick Heinegård & Anna Blom, 2012, In : Arthritis Research and Therapy. 14, 1, R15.

    Research output: Contribution to journalArticle

  27. 2011
  28. Cost-effectiveness of etanercept treatment in early active rheumatoid arthritis followed by dose adjustment.

    Gisela Kobelt, Ingrid Lekander, Andrea Lang, Bernd Raffeiner, Costantino Botsios & Pierre Geborek, 2011, In : International Journal of Technology Assessment in Health Care. 27, 3, p. 193-200

    Research output: Contribution to journalArticle

  29. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

    S. van Assen, N. Agmon-Levin, O. Elkayam, R. Cervera, M. F. Doran, M. Dougados, P. Emery, Pierre Geborek, J. P. A. Ioannidis, D. R. W. Jayne, C. G. M. Kallenberg, U. Mueller-Ladner, Y. Shoenfeld, L. Stojanovich, G. Valesini, N. M. Wulffraat & M. Bijl, 2011, In : Annals of the Rheumatic Diseases. 70, 3, p. 414-422

    Research output: Contribution to journalArticle

  30. Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register

    M. Neovius, J. F. Simard, A. Sundstrom, L Jacobsson, Pierre Geborek, Tore Saxne, N. Feltelius, L. Klareskog & J. Askling, 2011, In : Annals of the Rheumatic Diseases. 70, 3, p. 516-519

    Research output: Contribution to journalArticle

Previous 1 2 3 Next